Mineralocorticoid receptor antagonist added to angiotensin-converting enzyme inhibitor ameliorates the transition to diastolic heart failure by decreasing myocardial oxidative stress

被引：0
|
作者：
Kimata, H
Obata, K
Saka, M
Cheng, XW
Hayashi, K
Ichihara, S
机构：
[1] Nagoya Univ, Nagoya, Aichi, Japan
[2] Mie Univ, Tsu, Mie 514, Japan
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2183
引用
收藏
页码：U512 / U512
页数：1
相关论文
共 50 条
  • [21] Low rates of angiotensin-converting enzyme inhibitor use in congestive heart failure
    Stafford, RS
    Saglam, D
    Blumenthal, D
    CIRCULATION, 1996, 94 (08) : 1127 - 1127
  • [22] National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure
    Stafford, RS
    Saglam, D
    Blumenthal, D
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (21) : 2460 - 2464
  • [23] Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure
    Roe, CM
    Motheral, BR
    Teitelbaum, F
    Rich, MW
    AMERICAN HEART JOURNAL, 1999, 138 (05) : 818 - 825
  • [24] Myocardial Angiotensin-Converting Enzyme 2 Protein Expression in Ischemic Heart Failure
    Sirataviciute, Vitalija
    Pangonyte, Dalia
    Utkiene, Lina
    Jusiene, Lina
    Marcinkeviciene, Jolanta
    Stanioniene, Zita
    Radike, Reda
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [25] Angiotensin II receptor antagonist enhances the effects of angiotensin converting enzyme inhibitor in conscious pigs with congestive heart failure
    Shen, YT
    Lynch, JJ
    Wiedmann, RT
    Greenland, BD
    Grossman, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 76149 - 76149
  • [26] Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure
    Brackbill, Marcia L.
    Bashaw-Keaton, Rebecca
    Sytsma, Christine S.
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (10): : 568 - 570
  • [27] Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig
    Ryckwaert, F
    Colson, P
    André, E
    Perrigault, PF
    Guillon, G
    Barberis, C
    BRITISH JOURNAL OF ANAESTHESIA, 2002, 89 (04) : 599 - 604
  • [28] Rationale, background, and design of the randomized angiotensin receptor antagonist angiotensin-converting enzyme inhibitor study (RAAS)
    Pitt, B
    Chang, P
    Grossman, W
    Dunlay, M
    Timmermans, PBMWWM
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (10): : 1129 - 1131
  • [29] Benefits and Risks of Continuing Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Mineralocorticoid Receptor Antagonists during Hospitalizations for Acute Heart Failure
    Oliveros, Estefania
    Oni, Ebenezer T.
    Shahzad, Anum
    Kluger, Aaron Y.
    Lo, Kevin Bryan
    Rangaswami, Janani
    McCullough, Peter A.
    CARDIORENAL MEDICINE, 2020, 10 (02) : 69 - 84
  • [30] EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR AND ALDOSTERONE ANTAGONIST ON MYOCARDIAL COLLAGEN IN CARDIOMYOPATHIC HAMSTERS
    ARAKI, T
    SHIMIZU, M
    YOSHIO, H
    INO, H
    MABUCHI, H
    TAKEDA, R
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1995, 59 (04): : 213 - 218
12345